nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—Glyburide—gestational diabetes	0.25	0.437	CbGbCtD
Lapatinib—ABCB1—Glyburide—gestational diabetes	0.202	0.352	CbGbCtD
Lapatinib—CYP3A4—Glyburide—gestational diabetes	0.121	0.211	CbGbCtD
Lapatinib—TAP1—islet of Langerhans—gestational diabetes	0.0218	0.0853	CbGeAlD
Lapatinib—ERBB2—embryo—gestational diabetes	0.0154	0.0602	CbGeAlD
Lapatinib—ERBB4—embryo—gestational diabetes	0.0154	0.0602	CbGeAlD
Lapatinib—PI4KB—islet of Langerhans—gestational diabetes	0.0149	0.0583	CbGeAlD
Lapatinib—TAP1—adipose tissue—gestational diabetes	0.0139	0.0544	CbGeAlD
Lapatinib—PIK3C2B—adipose tissue—gestational diabetes	0.0131	0.0511	CbGeAlD
Lapatinib—TAP1—vagina—gestational diabetes	0.0116	0.0452	CbGeAlD
Lapatinib—PIK3C2B—vagina—gestational diabetes	0.0109	0.0424	CbGeAlD
Lapatinib—ERBB2—uterus—gestational diabetes	0.0104	0.0406	CbGeAlD
Lapatinib—ERBB2—adipose tissue—gestational diabetes	0.0102	0.0397	CbGeAlD
Lapatinib—ERBB4—adipose tissue—gestational diabetes	0.0102	0.0397	CbGeAlD
Lapatinib—PIK3C2B—head—gestational diabetes	0.01	0.0392	CbGeAlD
Lapatinib—PI4KB—uterus—gestational diabetes	0.00973	0.038	CbGeAlD
Lapatinib—PI4KB—adipose tissue—gestational diabetes	0.00951	0.0372	CbGeAlD
Lapatinib—EGFR—uterus—gestational diabetes	0.0088	0.0344	CbGeAlD
Lapatinib—EGFR—adipose tissue—gestational diabetes	0.00861	0.0337	CbGeAlD
Lapatinib—ERBB4—vagina—gestational diabetes	0.00844	0.033	CbGeAlD
Lapatinib—PI4KB—vagina—gestational diabetes	0.00791	0.0309	CbGeAlD
Lapatinib—ERBB2—head—gestational diabetes	0.0078	0.0305	CbGeAlD
Lapatinib—ERBB4—head—gestational diabetes	0.0078	0.0305	CbGeAlD
Lapatinib—PI4KB—head—gestational diabetes	0.0073	0.0286	CbGeAlD
Lapatinib—ERBB4—EV release from cardiac cells and their functional effects—TNF—gestational diabetes	0.00614	0.042	CbGpPWpGaD
Lapatinib—TAP1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.00584	0.04	CbGpPWpGaD
Lapatinib—ERBB2—Leptin signaling pathway—LEPR—gestational diabetes	0.00576	0.0394	CbGpPWpGaD
Lapatinib—PI4KB—Integrins in angiogenesis—FGF2—gestational diabetes	0.00419	0.0287	CbGpPWpGaD
Lapatinib—CYP3A5—islet of Langerhans—gestational diabetes	0.00391	0.0153	CbGeAlD
Lapatinib—EGFR—Signaling events mediated by PTP1B—LEPR—gestational diabetes	0.00373	0.0255	CbGpPWpGaD
Lapatinib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00297	0.119	CcSEcCtD
Lapatinib—CYP2C19—vagina—gestational diabetes	0.00263	0.0103	CbGeAlD
Lapatinib—CYP3A5—adipose tissue—gestational diabetes	0.00249	0.00974	CbGeAlD
Lapatinib—CYP2C8—vagina—gestational diabetes	0.00229	0.00897	CbGeAlD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.00218	0.0149	CbGpPWpGaD
Lapatinib—Renal failure acute—Glyburide—gestational diabetes	0.00213	0.0848	CcSEcCtD
Lapatinib—ABCB1—islet of Langerhans—gestational diabetes	0.00207	0.00811	CbGeAlD
Lapatinib—CYP3A5—vagina—gestational diabetes	0.00207	0.00809	CbGeAlD
Lapatinib—ERBB2—Leptin signaling pathway—LEP—gestational diabetes	0.00202	0.0138	CbGpPWpGaD
Lapatinib—ABCB1—embryo—gestational diabetes	0.00201	0.00784	CbGeAlD
Lapatinib—PIK3C2B—Metabolism—GGCT—gestational diabetes	0.0018	0.0123	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GGCT—gestational diabetes	0.00173	0.0119	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—GLS2—gestational diabetes	0.00157	0.0107	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GLS2—gestational diabetes	0.00152	0.0104	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.0014	0.0096	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—GGCT—gestational diabetes	0.00138	0.00946	CbGpPWpGaD
Lapatinib—ERBB2—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.00138	0.00942	CbGpPWpGaD
Lapatinib—ERBB4—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.00136	0.00928	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00136	0.00928	CbGpPWpGaD
Lapatinib—ABCB1—uterus—gestational diabetes	0.00135	0.00529	CbGeAlD
Lapatinib—TAP1—Immune System—MBL2—gestational diabetes	0.00133	0.00912	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00133	0.00911	CbGpPWpGaD
Lapatinib—ABCB1—adipose tissue—gestational diabetes	0.00132	0.00517	CbGeAlD
Lapatinib—EGFR—Signaling events mediated by PTP1B—LEP—gestational diabetes	0.00131	0.00897	CbGpPWpGaD
Lapatinib—ERBB2—PI-3K cascade—FGF2—gestational diabetes	0.00124	0.00849	CbGpPWpGaD
Lapatinib—ERBB4—PI-3K cascade—FGF2—gestational diabetes	0.00122	0.00836	CbGpPWpGaD
Lapatinib—ERBB2—PI3K/AKT activation—FGF2—gestational diabetes	0.00121	0.00828	CbGpPWpGaD
Lapatinib—ERBB2—GAB1 signalosome—FGF2—gestational diabetes	0.0012	0.00822	CbGpPWpGaD
Lapatinib—Alopecia—Glyburide—gestational diabetes	0.0012	0.0478	CcSEcCtD
Lapatinib—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.0012	0.0082	CbGpPWpGaD
Lapatinib—ERBB4—PI3K/AKT activation—FGF2—gestational diabetes	0.00119	0.00816	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—AR—gestational diabetes	0.00119	0.00811	CbGpPWpGaD
Lapatinib—ERBB4—GAB1 signalosome—FGF2—gestational diabetes	0.00118	0.0081	CbGpPWpGaD
Lapatinib—Malnutrition—Glyburide—gestational diabetes	0.00118	0.0471	CcSEcCtD
Lapatinib—ERBB2—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00117	0.00803	CbGpPWpGaD
Lapatinib—ERBB4—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00116	0.00791	CbGpPWpGaD
Lapatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00112	0.00765	CbGpPWpGaD
Lapatinib—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.0011	0.00755	CbGpPWpGaD
Lapatinib—ABCB1—vagina—gestational diabetes	0.0011	0.0043	CbGeAlD
Lapatinib—Anaemia—Glyburide—gestational diabetes	0.00109	0.0436	CcSEcCtD
Lapatinib—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.00107	0.00732	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00107	0.00731	CbGpPWpGaD
Lapatinib—Leukopenia—Glyburide—gestational diabetes	0.00106	0.0422	CcSEcCtD
Lapatinib—ABCB1—head—gestational diabetes	0.00102	0.00397	CbGeAlD
Lapatinib—Arthralgia—Glyburide—gestational diabetes	0.00101	0.0401	CcSEcCtD
Lapatinib—Myalgia—Glyburide—gestational diabetes	0.00101	0.0401	CcSEcCtD
Lapatinib—EGFR—MAPK Signaling Pathway—GCK—gestational diabetes	0.001	0.00686	CbGpPWpGaD
Lapatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000968	0.00662	CbGpPWpGaD
Lapatinib—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000955	0.00654	CbGpPWpGaD
Lapatinib—Nervous system disorder—Glyburide—gestational diabetes	0.000946	0.0377	CcSEcCtD
Lapatinib—ERBB2—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000927	0.00634	CbGpPWpGaD
Lapatinib—Anorexia—Glyburide—gestational diabetes	0.00092	0.0367	CcSEcCtD
Lapatinib—ERBB4—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000913	0.00625	CbGpPWpGaD
Lapatinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000906	0.0062	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000887	0.00607	CbGpPWpGaD
Lapatinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000879	0.035	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—GCK—gestational diabetes	0.000875	0.00599	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000874	0.00598	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—FGF2—gestational diabetes	0.000873	0.00597	CbGpPWpGaD
Lapatinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000864	0.00591	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—NAMPT—gestational diabetes	0.00086	0.00589	CbGpPWpGaD
Lapatinib—Dyspnoea—Glyburide—gestational diabetes	0.00086	0.0343	CcSEcCtD
Lapatinib—ERBB2—Innate Immune System—MBL2—gestational diabetes	0.00086	0.00588	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—FGF2—gestational diabetes	0.00086	0.00588	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—GCK—gestational diabetes	0.000855	0.00585	CbGpPWpGaD
Lapatinib—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000852	0.00583	CbGpPWpGaD
Lapatinib—Dyspepsia—Glyburide—gestational diabetes	0.000849	0.0339	CcSEcCtD
Lapatinib—ERBB4—Innate Immune System—MBL2—gestational diabetes	0.000847	0.0058	CbGpPWpGaD
Lapatinib—Decreased appetite—Glyburide—gestational diabetes	0.000839	0.0334	CcSEcCtD
Lapatinib—ERBB2—Downstream signal transduction—FGF2—gestational diabetes	0.000834	0.00571	CbGpPWpGaD
Lapatinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000833	0.0332	CcSEcCtD
Lapatinib—PI4KB—Metabolism—NAMPT—gestational diabetes	0.000831	0.00569	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—FGF2—gestational diabetes	0.00083	0.00568	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GCK—gestational diabetes	0.000826	0.00565	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—FGF2—gestational diabetes	0.000825	0.00565	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—FGF2—gestational diabetes	0.000821	0.00562	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—FGF2—gestational diabetes	0.000821	0.00562	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—FGF2—gestational diabetes	0.000817	0.00559	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—FGF2—gestational diabetes	0.000813	0.00556	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00081	0.00554	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—FGF2—gestational diabetes	0.000809	0.00554	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000798	0.00546	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000797	0.00546	CbGpPWpGaD
Lapatinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000789	0.0315	CcSEcCtD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000785	0.00537	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000777	0.00531	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—FGF2—gestational diabetes	0.000773	0.00529	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000773	0.00529	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000773	0.00529	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—FGF2—gestational diabetes	0.000767	0.00525	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—FGF2—gestational diabetes	0.000766	0.00524	CbGpPWpGaD
Lapatinib—Abdominal pain—Glyburide—gestational diabetes	0.000763	0.0304	CcSEcCtD
Lapatinib—ERBB4—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000761	0.00521	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—FGF2—gestational diabetes	0.000761	0.00521	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000761	0.00521	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000759	0.0052	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—FGF2—gestational diabetes	0.000756	0.00517	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—FGF2—gestational diabetes	0.000754	0.00516	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000748	0.00512	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—FGF2—gestational diabetes	0.000744	0.00509	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000727	0.00498	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—ADIPOQ—gestational diabetes	0.000721	0.00493	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—FGF2—gestational diabetes	0.000715	0.00489	CbGpPWpGaD
Lapatinib—Hypersensitivity—Glyburide—gestational diabetes	0.000711	0.0283	CcSEcCtD
Lapatinib—ERBB4—B Cell Activation—FGF2—gestational diabetes	0.000704	0.00482	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.0007	0.00479	CbGpPWpGaD
Lapatinib—Asthenia—Glyburide—gestational diabetes	0.000692	0.0276	CcSEcCtD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000684	0.00468	CbGpPWpGaD
Lapatinib—Pruritus—Glyburide—gestational diabetes	0.000683	0.0272	CcSEcCtD
Lapatinib—EGFR—Spinal Cord Injury—LEP—gestational diabetes	0.00068	0.00466	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000674	0.00461	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000669	0.00458	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000669	0.00458	CbGpPWpGaD
Lapatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.000666	0.00455	CbGpPWpGaD
Lapatinib—Diarrhoea—Glyburide—gestational diabetes	0.00066	0.0263	CcSEcCtD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000643	0.0044	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000643	0.0044	CbGpPWpGaD
Lapatinib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000642	0.0044	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CYP19A1—gestational diabetes	0.000625	0.00428	CbGpPWpGaD
Lapatinib—Vomiting—Glyburide—gestational diabetes	0.000613	0.0245	CcSEcCtD
Lapatinib—Rash—Glyburide—gestational diabetes	0.000608	0.0243	CcSEcCtD
Lapatinib—Dermatitis—Glyburide—gestational diabetes	0.000608	0.0242	CcSEcCtD
Lapatinib—Headache—Glyburide—gestational diabetes	0.000604	0.0241	CcSEcCtD
Lapatinib—PI4KB—Metabolism—CYP19A1—gestational diabetes	0.000604	0.00413	CbGpPWpGaD
Lapatinib—EGFR—PI-3K cascade—FGF2—gestational diabetes	0.0006	0.0041	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—FGF2—gestational diabetes	0.000585	0.00401	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—FGF2—gestational diabetes	0.000581	0.00397	CbGpPWpGaD
Lapatinib—Nausea—Glyburide—gestational diabetes	0.000573	0.0229	CcSEcCtD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.000567	0.00388	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000547	0.00374	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—FGF2—gestational diabetes	0.000526	0.0036	CbGpPWpGaD
Lapatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000519	0.00355	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—FGF2—gestational diabetes	0.000519	0.00355	CbGpPWpGaD
Lapatinib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000513	0.00351	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MBL2—gestational diabetes	0.000501	0.00343	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MBL2—gestational diabetes	0.000493	0.00338	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.000481	0.00329	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000475	0.00325	CbGpPWpGaD
Lapatinib—ERBB2—Disease—RBP4—gestational diabetes	0.000466	0.00319	CbGpPWpGaD
Lapatinib—TAP1—Immune System—FGF2—gestational diabetes	0.000465	0.00319	CbGpPWpGaD
Lapatinib—ERBB4—Disease—RBP4—gestational diabetes	0.000459	0.00314	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000448	0.00307	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—LEP—gestational diabetes	0.000448	0.00306	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000443	0.00303	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000429	0.00293	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000429	0.00293	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LEPR—gestational diabetes	0.000424	0.0029	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—GCK—gestational diabetes	0.000423	0.00289	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—FGF2—gestational diabetes	0.000422	0.00289	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000421	0.00288	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NAMPT—gestational diabetes	0.000418	0.00286	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LEPR—gestational diabetes	0.000417	0.00286	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000417	0.00285	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MBL2—gestational diabetes	0.000416	0.00284	CbGpPWpGaD
Lapatinib—ERBB2—Disease—GCK—gestational diabetes	0.000416	0.00284	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NAMPT—gestational diabetes	0.000412	0.00282	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000411	0.00281	CbGpPWpGaD
Lapatinib—ERBB4—Disease—GCK—gestational diabetes	0.000409	0.0028	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—FGF2—gestational diabetes	0.000403	0.00276	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—FGF2—gestational diabetes	0.000401	0.00274	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—FGF2—gestational diabetes	0.000399	0.00273	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—FGF2—gestational diabetes	0.000397	0.00272	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000391	0.00268	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000374	0.00256	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000374	0.00256	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—FGF2—gestational diabetes	0.000374	0.00256	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000372	0.00255	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—FGF2—gestational diabetes	0.00037	0.00253	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000367	0.00251	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000367	0.00251	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—FGF2—gestational diabetes	0.000365	0.0025	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000352	0.00241	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ADIPOQ—gestational diabetes	0.000348	0.00238	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—FGF2—gestational diabetes	0.000346	0.00237	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—FGF2—gestational diabetes	0.00034	0.00233	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MTNR1B—gestational diabetes	0.000335	0.00229	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000331	0.00226	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MTNR1B—gestational diabetes	0.00033	0.00226	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RBP4—gestational diabetes	0.000326	0.00223	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000325	0.00222	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RBP4—gestational diabetes	0.000322	0.0022	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—gestational diabetes	0.000315	0.00215	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—FGF2—gestational diabetes	0.0003	0.00205	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—FGF2—gestational diabetes	0.000296	0.00202	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—FGF2—gestational diabetes	0.000288	0.00197	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—FGF2—gestational diabetes	0.000284	0.00194	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—MTNR1B—gestational diabetes	0.000274	0.00188	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—FGF2—gestational diabetes	0.000255	0.00174	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MBL2—gestational diabetes	0.000242	0.00166	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—gestational diabetes	0.000237	0.00162	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GGCT—gestational diabetes	0.000236	0.00162	CbGpPWpGaD
Lapatinib—EGFR—Disease—RBP4—gestational diabetes	0.000225	0.00154	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000224	0.00153	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000221	0.00151	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000219	0.0015	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—LEP—gestational diabetes	0.000216	0.00148	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000214	0.00146	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—gestational diabetes	0.000207	0.00142	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GLS2—gestational diabetes	0.000207	0.00141	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEPR—gestational diabetes	0.000205	0.0014	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GGCT—gestational diabetes	0.000205	0.0014	CbGpPWpGaD
Lapatinib—EGFR—Disease—NAMPT—gestational diabetes	0.000202	0.00138	CbGpPWpGaD
Lapatinib—EGFR—Disease—GCK—gestational diabetes	0.000201	0.00137	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GGCT—gestational diabetes	0.000183	0.00125	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000181	0.00124	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GLS2—gestational diabetes	0.000179	0.00123	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GGCT—gestational diabetes	0.000178	0.00122	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000177	0.00121	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FGF2—gestational diabetes	0.000175	0.0012	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FGF2—gestational diabetes	0.000172	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—FGF2—gestational diabetes	0.000164	0.00112	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MTNR1B—gestational diabetes	0.000162	0.00111	CbGpPWpGaD
Lapatinib—ERBB2—Disease—FGF2—gestational diabetes	0.000161	0.00111	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00016	0.0011	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GLS2—gestational diabetes	0.00016	0.00109	CbGpPWpGaD
Lapatinib—ERBB4—Disease—FGF2—gestational diabetes	0.000159	0.00109	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RBP4—gestational diabetes	0.000158	0.00108	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GLS2—gestational diabetes	0.000156	0.00107	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LEP—gestational diabetes	0.000149	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LEP—gestational diabetes	0.000147	0.001	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FGF2—gestational diabetes	0.000145	0.000993	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000143	0.000978	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—FGF2—gestational diabetes	0.000139	0.000954	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	0.000113	0.000775	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGF2—gestational diabetes	0.000113	0.000774	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GCK—gestational diabetes	0.000113	0.00077	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGF2—gestational diabetes	0.000111	0.000762	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GGCT—gestational diabetes	0.00011	0.000752	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000108	0.000739	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—gestational diabetes	0.0001	0.000685	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NAMPT—gestational diabetes	9.81e-05	0.000671	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GCK—gestational diabetes	9.75e-05	0.000667	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GLS2—gestational diabetes	9.61e-05	0.000658	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NAMPT—gestational diabetes	8.76e-05	0.000599	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCK—gestational diabetes	8.7e-05	0.000595	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NAMPT—gestational diabetes	8.55e-05	0.000585	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCK—gestational diabetes	8.49e-05	0.000581	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGF2—gestational diabetes	8.45e-05	0.000579	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	8.23e-05	0.000563	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGF2—gestational diabetes	7.81e-05	0.000534	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—gestational diabetes	7.2e-05	0.000492	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	7.13e-05	0.000488	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	6.36e-05	0.000435	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	6.21e-05	0.000425	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGF2—gestational diabetes	5.47e-05	0.000374	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	5.26e-05	0.00036	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCK—gestational diabetes	5.23e-05	0.000358	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	3.83e-05	0.000262	CbGpPWpGaD
